Gaithersburg-based NexImmune, a biotech developing immunotherapy treatments for cancer, has been acquired by a consortium of big-name biotech veterans and investors.
{iframe}http://www.bizjournals.com/washington/news/2017/02/14/roivant-sciences.html{/iframe}